Passing of Biosecure Act a positive development
Jonathan Hunt MD and CEO, Syngene International analyses that though the change in the Biosecure Act around the timeline of…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Syngene International
Syngene announces 2nd year of STEM scholarship and mentorship program for women in collaboration…
30 women from tier 2 and 3 institutions have been selected for the second cohort of the program
Syngene biologics facility to be operational for US, European customers from mid-year
New facility includes 20KL of single use drug substance capacity coupled with drug product filling capacity of up to one million…
Syngene concludes acquisition of biologics facility from Stelis Biopharma
The acquisition of the ‘Unit 3’ biologics manufacturing facility was concluded at a revised gross value of Rs 617 crores adjusted…
Panbela announces issuance of key patent in Japan
The patent, developed in collaboration with Syngene International, is for claims of a novel process for the production of SBP-101
Syngene reports Q2 results
Revenue from operations up 26 per cent to Rs 768 crore, PAT increased 11 per cent to Rs 102 crore
Syngene reports full year revenue from operations up 19 per cent to Rs 2,604 crores
Revenue from operations up 15 per cent to Rs 758 crores in fourth quarter
Syngene International announces extension of collaboration with Amgen Contract extended until 2026
Under the extended contract, the dedicated R&D centre, ‘Syngene Amgen Research and Development Center’ (SARC), will continue…
Syngene expands biopharma-manufacturing capacity
The company sets up a state-of-the-art microbial facility; expands mammalian facility
Syngene appoints two senior leaders in US
While Alex Del Priore has been appointed as Senior Vice President, Manufacturing Services; Alan Collis has been appointed as Vice…